Cargando…

The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates

Detalles Bibliográficos
Autor principal: Curtiss, Frederic R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437304/
https://www.ncbi.nlm.nih.gov/pubmed/14664669
http://dx.doi.org/10.18553/jmcp.2003.9.6.573a
_version_ 1785092489572515840
author Curtiss, Frederic R.
author_facet Curtiss, Frederic R.
author_sort Curtiss, Frederic R.
collection PubMed
description
format Online
Article
Text
id pubmed-10437304
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104373042023-08-21 The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates Curtiss, Frederic R. J Manag Care Pharm Editorial Subjects In This Issue Academy of Managed Care Pharmacy 2003-11 /pmc/articles/PMC10437304/ /pubmed/14664669 http://dx.doi.org/10.18553/jmcp.2003.9.6.573a Text en Copyright © 2003, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Editorial Subjects In This Issue
Curtiss, Frederic R.
The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
title The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
title_full The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
title_fullStr The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
title_full_unstemmed The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
title_short The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
title_sort relative value of disease management programs versus drug manufacturer rebates
topic Editorial Subjects In This Issue
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437304/
https://www.ncbi.nlm.nih.gov/pubmed/14664669
http://dx.doi.org/10.18553/jmcp.2003.9.6.573a
work_keys_str_mv AT curtissfredericr therelativevalueofdiseasemanagementprogramsversusdrugmanufacturerrebates
AT curtissfredericr relativevalueofdiseasemanagementprogramsversusdrugmanufacturerrebates